Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Dose-Finding Study to Assess the Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

NCT07752979 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT07752979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07752979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Dose-Finding Study to Assess the Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Lead sponsor
AbbVie
Phase
Phase 2
Overall status
Recruiting
Start date
August 4, 2026
Completion date
March 31, 2028
Enrollment
360 (estimated)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, overweight